Blueprint Medicines Reports Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: BPMC) | Delayed: 129.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.46 | 52 Week High | $35.96 | |||
| Open | $129.46 | 52 Week Low | $13.04 | |||
| Day High | $129.46 | P/E | N/A | |||
| Day Low | $129.46 | EPS | $0.00 | |||
| Volume | 25 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 63.25 +1.10 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.15 | 52 Week High | $3.48 | |||
| Open | $62.34 | 52 Week Low | $0.80 | |||
| Day High | $63.29 | P/E | N/A | |||
| Day Low | $62.34 | EPS | $-1.54 | |||
| Volume | 201,318 | |||||
